Antioxidant properties of macrophages toward low-density lipoprotein

Trends in Cardiovascular Medicine

Volumn 11, Issue 1, 2001, Pages 1-7

  Baoutina, Anna ^a   Dean, Roger T ^a   Jessup, Wendy ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HYDROPEROXIDE; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN; METAL; PROTEIN; PROTEIN HYDROPEROXIDE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL TYPE; DETOXIFICATION; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTECTION; PROTEIN MODIFICATION; REVIEW;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CHOLESTEROL ESTERS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; METALS; OXIDATION-REDUCTION;

EID: 0034965077     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00075-5     Document Type: Review

References (41)

1. α-Tocopherol supplementation of macrophages does not influence their ability to oxidise LDL
2. Macrophages can decrease the level of cholesteryl ester hydroperoxides in low density lipoprotein
3. Trans-plasma membrane electron transport induces macrophage-mediated low density lipoprotein oxidation
4. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols
5. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation
6. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque
7. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries
8. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque
9. Biological fate of amino acid, peptide and protein hydroperoxides
10. Cell-mediated oxidation of low-density lipoprotein; the elusive mechanism(s)
11. Direct copper reduction by macrophages. Its role in low density lipoprotein oxidation
12. 7,8 Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an anti-oxidant
13. Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism
14. Detection of activated T lymphocytes in the human atherosclerotic plaque
15. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes; pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo
16. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages
17. Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages
18. Effects of hypertension on aortic antioxidant status in human abdominal aneurysmal and occlusive disease
19. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides
20. Oxidized lipoproteins and nitric oxide
21. Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution
22. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima
23. Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein
24. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions; colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins
25. Molecular role of ascorbate in enhancement of NO production in activated macrophage-like cell line, J774.1
26. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation
27. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques
28. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL; in vitro and in vivo studies
29. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C
30. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo; the roles of macrophages, endogenous IFN-gamma, and TNF receptor-1-mediated signaling
31. Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters
32. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells; presence in human plasma
33. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions
34. Low density lipoprotein oxidation and its pathobiological significance
35. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate
36. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages
37. Enzymatic reduction of phospholipid and cholesterol hydroperoxides in artificial bilayers and lipoproteins
38. Antioxidant activities and redox regulation of interferon-gamma-induced trytophan metabolism in human monocytes and macrophages
39. Prooxidant and antioxidant activities of macrophages in metal-mediated LDL oxidation; the importance of metal sequestration
40. Is oxidized low-density lipoprotein present in vivo?
41. Inhibitory effect of tea flavonoids on the ability of cells to oxidize low density lipoprotein